Evidence map›Paper›PMID 21896815›Full record

Trial reportThe American journal of tropical medicine and hygiene2011

Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia.

Teshome Gebre, Berhan Ayele, Mulat Zerihun, Jenafir I House, Nicole E Stoller, Zhaoxia Zhou, Kathryn J Ray, Bruce D Gaynor, Travis C Porco, Paul M Emerson and 2 more

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of tropical medicine and hygiene, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00322972 (Eliminating Trachoma With Repeat Mass Drug Treatment), which is not on this map. Cited by 13 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 5 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00322972 phase4completednot on this map

Eliminating Trachoma With Repeat Mass Drug Treatment

TypeinterventionalSponsorUniversity of California, San FranciscoRan2006 to 2014Enrolled33,000ConditionsTrachoma, ChlamydiaArmsMass treatment with oral azithromycin to an entire community
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 5 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Antibiotics for trachoma.The Cochrane database of systematic reviews · 2019
    Pooled it
  5. Trachoma.BMJ clinical evidence · 2016
    Pooled it
  6. Review
  7. Article
  8. Article
  9. Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Trachoma: an update on prevention, diagnosis, and treatment.Current opinion in ophthalmology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Teshome GebreCarter Center Ethiopia, Addis Ababa, Ethiopia.
Berhan Ayele
Mulat Zerihun
Jenafir I House
Nicole E Stoller
Zhaoxia Zhou
Kathryn J Ray
Bruce D Gaynor
Travis C Porco
Paul M Emerson
Thomas M Lietman
Jeremy D Keenan
The Carter Center · ET

Funding

CTSA: K12 COMPONENTKL2RR024130 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$19.3M
TANA IIU10EY016214 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M · 2004 to 2013
$4.4M
Optimal trachoma control after mass antibiotic distributionsK23EY019071 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KEENAN, JEREMY DAVID · 2008 to 2012
$982k
NCRR NIH HHS KL2 RR024130NEI NIH HHS K23 EY019071NEI NIH HHS U10 EY016214
6 · The paper itself

Abstract

Trachoma control strategies, including latrine construction and antibiotic distribution, are directed at reducing ocular chlamydia, but may have additional benefits. In a cluster-randomized clinical trial, 24 subkebeles (administrative geographic units) in Ethiopia were offered a single mass azithromycin treatment, and half were randomized to receive an intensive latrine promotion. At a follow-up census 26 months after the baseline treatment, 320 persons had died. The mortality rate of children 1-5 years of age was 3.87 (95% confidence interval [CI] = 2.19-6.82) per 1,000 person-years in the latrine promotion arm, and 2.72 (95% CI = 1.37-5.42) per 1,000 person-years in the control arm. In a multi-level mixed effects logistic regression model controlling for age, there was no difference in mortality in persons randomized into the latrine or control arms (odds ratio = 1.18, 95% CI = 0.89-1.58). Latrine promotion provided no additional effect on mortality in the context of an azithromycin distribution program (clinicaltrials.gov, #NCT00322972).

Indexed as

Toilet FacilitiesAdolescentAnti-Bacterial AgentsAzithromycinChildChild, PreschoolCluster AnalysisEthiopiaFemaleHumansInfantMaleOdds RatioTrachomaYoung AdultAnti-Bacterial AgentsAzithromycin

Identifiers

PMID21896815
PMCPMC3163877
OpenAlexW2169208260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.